title: The social consequences for families with Alzheimer's disease patients: potential impact of new drug treatment.
abstract: The social consequences of Alzheimer's disease are highlighted in this review with regard to impact on family situation, a changing treatment context caused by demographic changes, reorganization of long-term care, a financial crisis in the public health systems and the introduction of antidementia drugs. In the early phase of dementia there may be significant consequences for the patients and the family members which are largely unrecognized by the healthcare system. As the disease progresses, the impact on caregivers in terms of physical and emotional burden, financial and employment status may be enormous. The current care provision in Sweden, the UK and The Netherlands is described. Innovative care alternatives and strategies may improve the situation. The introduction of antidementia drugs such as the acetylcholine esterase inhibitors may also contribute to improved circumstances for patients and caregivers. There is still a great need for further research in this field.
authors.affiliation: Research Unit of Primary Health Care in Nordanstig, Bergsjö, Sweden. Wimo@fammed.umu.se
authors.forename: A
authors.initials: A
authors.lastname: Wimo
authors.forename: B
authors.initials: B
authors.lastname: Winblad
authors.forename: M
authors.initials: M
authors.lastname: Grafstrom
mesh_terms: D000203:Activities of Daily Living; D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000191:economics / Q000523:psychology; D017028:Caregivers / Q000523:psychology*; D005060:Europe; D005260:Female; D006801:Humans; D008297:Male; D018697:Nootropic Agents / Q000627:therapeutic use*; D011788:Quality of Life; D012917:Social Adjustment; D012920:Social Behavior Disorders / Q000517:prevention & control; D012944:Social Support; D014481:United States
chemical_list: D018697:Nootropic Agents